Takeda Pharmaceutical Co Adr (TAK)

Feb 06, 2026

Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management - GlobeNewswire Inc.

Feb 06, 2026

Feb 03, 2026

FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Feb 03, 2026

Feb 03, 2026

Earnings call transcript: Takeda beats Q3 2025 forecasts, stock climbs - Investing.com

Feb 03, 2026

Feb 02, 2026

Takeda Pharmaceutical ADR: Defensive Pharma Giant Tests Investor Patience as Shares Drift Near Lows - AD HOC NEWS

Feb 02, 2026

Jan 31, 2026

Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026? - Finviz

Jan 31, 2026

Jan 31, 2026

Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone - Yahoo Finance

Jan 31, 2026

Jan 30, 2026

Takeda Pharma ADR earnings beat by $0.04, revenue topped estimates - Investing.com Australia

Jan 30, 2026

Jan 30, 2026

Stocks To Watch: Takeda Pharmaceutical ADR Sees Relative Strength Rating Rise To 83 - Investor's Business Daily

Jan 30, 2026

Jan 29, 2026

Takeda Q3 FY2025 slides: Revenue dips 3.3% as company preps key 2026 launches - Investing.com

Jan 29, 2026

Jan 29, 2026

Earnings call transcript: Takeda Pharma Q3 2026 sees mixed performance - Investing.com

Jan 29, 2026

Jan 28, 2026

Apple, Visa, KLA-Tencor and more set to report earnings Thursday By Investing.com - Investing.com Nigeria

Jan 28, 2026

Jan 26, 2026

Takeda Pharmaceutical ADR Gets Technical Rating Upgrade - Investor's Business Daily

Jan 26, 2026

Jan 25, 2026

Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily

Jan 25, 2026

Jan 23, 2026

US earnings seasonQ4 2025 - Interactive Investor

Jan 23, 2026

Jan 22, 2026

ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz

Jan 22, 2026

Jan 15, 2026

KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026? - Finviz

Jan 15, 2026

Jan 09, 2026

Takeda Pharmaceutical ADR Sees IBD RS Rating Climb To 76 - Investor's Business Daily

Jan 09, 2026

Jan 07, 2026

Book value per share of Takeda Pharmaceutical Co. Ltd. Sponsored ADR – GETTEX:TKDA - TradingView — Track All Markets

Jan 07, 2026

Jan 05, 2026

The Truth About Takeda Pharmaceutical Co Ltd: Is This Pharma Giant a Hidden Power Play for Your Port - AD HOC NEWS

Jan 05, 2026

Jan 05, 2026

G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.

Jan 05, 2026

Dec 31, 2025

Ethic Inc. Buys 43,295 Shares of Takeda Pharmaceutical Co. $TAK - Defense World

Dec 31, 2025

Dec 29, 2025

Takeda Pharmaceutical (NYSE:TAK) Strengthens Position in Healthcare - Kalkine Media

Dec 29, 2025

Dec 24, 2025

Takeda Pharmaceutical Co Ltd (TAK) Bonds - GuruFocus

Dec 24, 2025

Dec 19, 2025

Takeda Pharmaceutical Co Ltd ADR Stock Price Today | NYSE: TAK Live - Investing.com

Dec 19, 2025

Dec 06, 2025

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - GlobeNewswire Inc.

Dec 06, 2025

Dec 05, 2025

Denali Enters Into a $275M Funding Deal With Royalty Pharma - Finviz

Dec 05, 2025

Dec 04, 2025

INNOVENT BIO Completes Introduction of Takeda, Raising ~HKD780M Net - AASTOCKS.com

Dec 04, 2025

Dec 02, 2025

TAK vs. DSNKY: Which Stock Is the Better Value Option? - MSN

Dec 02, 2025

Nov 18, 2025

Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Nov 18, 2025

Nov 04, 2025

Coca-Cola Upgraded, Boeing Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Nov 04, 2025

Nov 02, 2025

ADR movements on the 11th: In yen terms, Kirin HD, Takeda Pharmaceutical, and Mitsui Metals showed gains. - 富途牛牛

Nov 02, 2025

Oct 30, 2025

Takeda Pharma ADR earnings beat by $278.84, revenue fell short of estimates - Investing.com Nigeria

Oct 30, 2025